LakePharma offers a comprehensive suite of lentivirus services, from vector engineering and production through analytics.  We utilize the third generation four plasmid system and the HEK293 cell line for the production of lentiviruses.  Custom vector design and development for the production of a variety of molecules, including CARs, is available. 

Key Features of Lentivirus Platform 

- Used for CAR-T and cell line engineering

- 3rd generation, four plasmid system

- Produced in HEK293-based system

  • Adherent & suspension

- Standard titer: 107 to 109 IFU/mL

- Pseudotyping

CAR Vector Selections Available

In addition to lentivirus production, LakePharma also offers cell engineering services, including CAR-T.

Click here to download our Viral Vector Presentation

Case study: Purity and Identity Characterization of AAV Capsid Particles by LC-MS Methods in collaboration with Agilent